{"name":"Charsire Biotechnology Corp.","slug":"charsire-biotechnology-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BAC treatment","genericName":"BAC treatment","slug":"bac-treatment","indication":"Hypertension","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CSTC1","genericName":"CSTC1","slug":"cstc1","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BAC treatment","genericName":"BAC treatment","slug":"bac-treatment","phase":"phase_2","mechanism":"BAC treatment works by inhibiting the activity of a specific enzyme.","indications":["Hypertension"],"catalyst":""},{"name":"CSTC1","genericName":"CSTC1","slug":"cstc1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOMXl3MVhSUm1CSmREdzgxRzAtNnZCemk0ay1rNWtXRGg3RUtBT0VJV0NIOG1jUzhJeGRua3FnVG50YmVoa2gxelM1OG5qWUlWZjU1S2VMWi1IR25LeWFtS1VBMjdTbXE0ZWsxb1REQ0dSdzRXX2daaFpCMEVBbmJ5bTd4TFB1VjE4OUQ1RkpVNDZtLUlDVXBJNkln?oc=5","date":"2025-04-22","type":"pipeline","source":"BioSpace","summary":"BIO Asia-Taiwan Kicks Off on an Expanded Scale July 23 - BioSpace","headline":"BIO Asia-Taiwan Kicks Off on an Expanded Scale July 23","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNOWZFRzNRdkNQZm1TUkFPa0w5cnJRbk9QVU43dTRWd21PYTU5b0xKaEV6OEhxNXJLblA1Rmd4VUJPdEFnLVo2c1lrWkhoZDJKdlJUV2tBSk91THZhUVdQZTloaFdSOEFXeGNORnczR0JCYnlLbXJCWExTVFRCT0EyYkVHOEJkZw?oc=5","date":"2025-04-11","type":"pipeline","source":"Future Market Insights","summary":"Vascular Dementia Treatment Market 2025 to 2035 - Future Market Insights","headline":"Vascular Dementia Treatment Market 2025 to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQTk1RjhIcHNLLWhTYVRZVmtIRUY0TjhlWG9lTmE1bERLbXZRTjlZa1k1c2xZY0hTUXV3bVhia19MZGRLM3NhVEFoMkkwUU8wdjNEeHVvRW9Ua25VeGRKQWlUbHJhMEFyeDhVLS1fem13QTRvTElTakFMRHlGWkR0amNsYm9QVFBHeUxR?oc=5","date":"2024-05-10","type":"trial","source":"openPR.com","summary":"Dementia Market 2032: Epidemiology Data, Pipeline - openPR.com","headline":"Dementia Market 2032: Epidemiology Data, Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNWmZEb1NLMVM0d2pXN1liQUNzdmN4SnVydmFVUzJHR1FmeUltd2FNdU1sMVVEWTlVZUlpc2h6ejJXdXRlZUxuS3UyMWVNd3dLRmdHeXIycTRSNG5JUUJFVE9OS045WGpyaUNEd1UyR1FqYWtsdjkwckJVLWVsdWpTakE2aGVCcUMwaUh0eVZIY2dkS1JZQkd0Z2V5c2dYLXdaMnA2anJlMW5IN0loWlhaakhvTUxIWHZPZ01rQTBNZERuSjB5LXZfUVVXMkFIWXgzZTVXcjJDRy0?oc=5","date":"2022-09-22","type":"pipeline","source":"BioSpectrum Asia","summary":"Charsire Biotech brings new drug to capture multi-billion-dollar dementia treatment market - BioSpectrum Asia","headline":"Charsire Biotech brings new drug to capture multi-billion-dollar dementia treatment market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQOGtTV21Ec25WMUlpMHU1cGtoZ0puWkw2ajB1MVJ2TTRmYkd2eTZsZGU4Y2M4RHlLeHlIN2lWNXR2ZUZ3NlZMeUlWLUNCUWtIX2RsVU5fcWxyMHRTdEdoVWo1TUQtOXdyV2tZaEdYVkFWNlIxNU9CSFR5bS1ITy00dzhIaGMwNVRpT0VrNGJpZERoZGUwQmhGYjU0dEtkUGJnMmJLajMwYTA1SUxoMU0zT0hKZ08teDlObGJydENNY1ZrZmJ1a2lqVm9Fc1lKcm9OVWVzSVlZeG04M1FKNURPSnNzb0ZqWThLWUJJWWhOcmhTNDJUN2tHTThYNG5LaGFJdnRWRzVqcW1Sa2lDd2VudHBUbHozbHNXQ1QxcEhn?oc=5","date":"2022-04-07","type":"trial","source":"PR Newswire UK","summary":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estimates DelveInsight - PR Newswire UK","headline":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estim","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}